JP2005525350A - Iodination of 4-fluoro-benzaldehyde - Google Patents

Iodination of 4-fluoro-benzaldehyde Download PDF

Info

Publication number
JP2005525350A
JP2005525350A JP2003569588A JP2003569588A JP2005525350A JP 2005525350 A JP2005525350 A JP 2005525350A JP 2003569588 A JP2003569588 A JP 2003569588A JP 2003569588 A JP2003569588 A JP 2003569588A JP 2005525350 A JP2005525350 A JP 2005525350A
Authority
JP
Japan
Prior art keywords
acid
fluoro
benzaldehyde
iodination
inorganic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003569588A
Other languages
Japanese (ja)
Inventor
ビツテンバーガー,ステーブン・ジエイ
チヤン,シユー−イエン
ウエイン,グレゴリー・エス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2005525350A publication Critical patent/JP2005525350A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms

Abstract

本発明は、置換されたベンズアルデヒドをヨウ素化するための改良された方法に関する。The present invention relates to an improved process for iodination of substituted benzaldehydes.

Description

カリウムチャンネルは、細胞膜の興奮の調整において、重要な役割を果たす。カリウムチャンネルが開くときに、細胞膜を横切って電位に変化が生じ、その結果としてさらなる分極状態となる。多くの病気又は病状が、カリウムチャンネルを開く治療剤によって治療され得る;例えば、(K.Lawson,Pharmacol.Ther.,第70巻,39−63頁(1996));(D.R.Gehlert等,Prog.Neuro−Psychopharmacol & Biol.Psychiat.,第18巻,1093−1102頁(1994));(M.Gopalakrishnan等,Drug Development Reserch,第28巻,95−127頁(1993));(J.E.Freedman等,The Neuroscientist,第2巻,145−152頁(1996));(D.E.Nurse等,Br.J.Urol.,第68巻 27−31頁(1991));(B.B.Howe等,J.Pharmacol.Exp.Ther.,第274巻 884−890頁(1995));(D.Spanswick等,Nature,第390巻 521−25頁(1997年12月4日));(Dompeling Vasa.Supplementum(1992)3434);(WO9932495);(Grover,J Mol Cell Cardiol.(2000)32,677);及び(Buchheit,Pulmonary Pharmacology & Therapeutics(1999)12,103)を参照されたい。前記の病気又は病状には、喘息、癲癇、男性機能障害、女性機能障害、疼痛、膀胱過活動、脳卒中、レイノー現象及び間欠性跛行のような骨血流量の減少に伴う病気、摂食障害、機能性腸疾患、神経変性、良性前立腺過形成(BPH)、月経困難症、早産、脱毛、心臓保護、冠動脈疾患、アンギナ、虚血、及び失禁が含まれる。   Potassium channels play an important role in regulating cell membrane excitation. When the potassium channel opens, a change in potential occurs across the cell membrane, resulting in a further polarization state. Many diseases or conditions can be treated with therapeutic agents that open potassium channels; for example, (K. Lawson, Pharmacol. Ther., 70, 39-63 (1996)); (DR Gehrert et al. , Prog. Neuro-Psychopharmacol & Biol. Psychiat., 18, pp. 1093-1102 (1994)); (E. Freeman et al., The Neuroscientist, Volume 2, pages 145-152 (1996)); (DE Nurse et al., Br. J. Urol., Volume 68 pages 27-31 (1991)); BB How , J. Pharmacol. Exp. Ther., 274, 884-890 (1995)); (D. Spanswick et al., Nature, 390, 521-25 (December 4, 1997)); Vasa.Supplementum (1992) 3434); (WO9932495); (Glover, J Mol Cell Cardiol. (2000) 32,677); and (Buchheit, Pulmonary Pharmacology & Therapeutics (see 1999) 12, 103). The above diseases or conditions include asthma, epilepsy, male dysfunction, female dysfunction, pain, bladder overactivity, stroke, Raynaud's phenomenon and intermittent claudication, bone loss, eating disorders, function Genital bowel disease, neurodegeneration, benign prostatic hyperplasia (BPH), dysmenorrhea, premature birth, hair loss, cardioprotection, coronary artery disease, angina, ischemia, and incontinence.

4−フルオロ−3−ヨード−ベンズアルデヒドは、これまでに、スキーム1に示される5工程で合成された。要約すれば、4−フルオロ安息香酸(1)を、4−フルオロ−3−ニトロ安息香酸(2)に変換して、その後、対応するアミン(3)に還元する。さらに還元してアルコール(4)にして、引き続いてヨウ素化(5)し、酸化して、最終的にヨウ素化ベンズアルデヒド(6)とする。   4-Fluoro-3-iodo-benzaldehyde has so far been synthesized in 5 steps as shown in Scheme 1. In summary, 4-fluorobenzoic acid (1) is converted to 4-fluoro-3-nitrobenzoic acid (2) and then reduced to the corresponding amine (3). Further reduction to alcohol (4), followed by iodination (5), oxidation, and finally iodinated benzaldehyde (6).

Figure 2005525350
Figure 2005525350

4−フルオロ−3−ヨードベンズアルデヒドの他の合成方法は、スキームIIに示される。4−フルオロ−3−ブロモ−ベンズアルデヒドが出発原料としては比較的高価であり、本方法が低温条件を必要とすることから、本方法は不利である。   Another method for the synthesis of 4-fluoro-3-iodobenzaldehyde is shown in Scheme II. This process is disadvantageous because 4-fluoro-3-bromo-benzaldehyde is relatively expensive as a starting material and the process requires low temperature conditions.

Figure 2005525350
Figure 2005525350

本発明は、カリウムチャンネル開口剤であるジヒドロピリジンの合成に有用な中間体の合成方法に関する。   The present invention relates to a method for synthesizing intermediates useful in the synthesis of dihydropyridine, a potassium channel opener.

(発明の詳細な説明)
本発明は、4−フルオロ−ベンズアルデヒドのヨウ素化による4−フルオロ−3−ヨード−ベンズアルデヒドの効率的な合成に関する。4−フルオロ−3−ヨード−ベンズアルデヒドは、カリウムチャンネル開口剤である5−(4−フルオロ−3−ヨードフェニル)−5,10ジヒドロ−1H,3H−ジピラノ[3,4−b:4,3−e]ピリジン−4,6(7H,9H)ジオンの製造における鍵となる中間体である。
(Detailed description of the invention)
The present invention relates to an efficient synthesis of 4-fluoro-3-iodo-benzaldehyde by iodination of 4-fluoro-benzaldehyde. 4-Fluoro-3-iodo-benzaldehyde is a potassium channel opener 5- (4-fluoro-3-iodophenyl) -5,10 dihydro-1H, 3H-dipyrano [3,4-b: 4,3 -E] is a key intermediate in the production of pyridine-4,6 (7H, 9H) dione.

本発明は、ベンズアルデヒドのヨウ素化のための改良された方法に関する。スキームIIIに示されるように、この改良された方法は、1工程の手順での4−フルオロ−3−ヨード−ベンズアルデヒドの合成を可能にする。4−フルオロ−3−ヨードベンズアルデヒドは、4−フルオロベンズアルデヒドとN−ヨードスクシンイミドとを酸媒体中で合わせることによって合成される。好ましくは、4−フルオロ−3−ヨードベンズアルデヒドとN−ヨードスクシンイミドは、それぞれ1:1.2の当量比にある。   The present invention relates to an improved process for iodination of benzaldehyde. As shown in Scheme III, this improved method allows the synthesis of 4-fluoro-3-iodo-benzaldehyde in a one-step procedure. 4-Fluoro-3-iodobenzaldehyde is synthesized by combining 4-fluorobenzaldehyde and N-iodosuccinimide in an acid medium. Preferably, 4-fluoro-3-iodobenzaldehyde and N-iodosuccinimide are each in an equivalent ratio of 1: 1.2.

本発明における使用に適した酸には、有機酸及び無機酸が含まれる。本発明における使用に適した有機酸の例には、トリフルオロメタンスルホン酸が含まれるがこれに限定されない。   Acids suitable for use in the present invention include organic and inorganic acids. Examples of organic acids suitable for use in the present invention include, but are not limited to, trifluoromethanesulfonic acid.

無機酸も同様に、本発明における使用に適している。本発明における使用に適した無機酸には、硝酸、硫酸、及び塩酸が含まれるがこれらに限定されない。   Inorganic acids are likewise suitable for use in the present invention. Inorganic acids suitable for use in the present invention include, but are not limited to, nitric acid, sulfuric acid, and hydrochloric acid.

上記無機酸は、また、酢酸と組み合わせて使用されてもよい。酢酸は溶解性の目的で使用される。強無機酸/酢酸の組み合わせが、本発明における使用に適している。好ましくは、無機酸/酢酸の組み合わせは、1:1の比率にある。   The inorganic acid may also be used in combination with acetic acid. Acetic acid is used for solubility purposes. Strong inorganic acid / acetic acid combinations are suitable for use in the present invention. Preferably, the inorganic acid / acetic acid combination is in a 1: 1 ratio.

Figure 2005525350
Figure 2005525350

4−フルオロベンズアルデヒド(40.0g)、N−ヨードスクシンイミド(87.1g)、及び酢酸(80mL)をフラスコに添加した。40℃より低い温度に維持して、硫酸(80mL)をゆっくりと添加する。得られた混合物を40℃で2.5時間攪拌して、その後、10℃に冷却した後に、35℃より低い温度に維持しながら、水(400mL)を添加した。室温で30分間攪拌した後、スラリーを濾過し、得られた固形物を水(80mL)で洗浄した。ウエットケーキを380gの酢酸エチル/ヘプタン(1:1v/v 250ppmのBHTを含有)に溶解し、溶液を、10%チオ硫酸ナトリウム水溶液(204g)で洗浄し、その後10%炭酸ナトリウム水溶液(214g)で洗浄し、続けて200gの水で洗浄した。   4-Fluorobenzaldehyde (40.0 g), N-iodosuccinimide (87.1 g), and acetic acid (80 mL) were added to the flask. Sulfuric acid (80 mL) is added slowly, maintaining the temperature below 40 ° C. The resulting mixture was stirred at 40 ° C. for 2.5 hours, then cooled to 10 ° C. and then water (400 mL) was added while maintaining the temperature below 35 ° C. After stirring at room temperature for 30 minutes, the slurry was filtered and the resulting solid was washed with water (80 mL). The wet cake is dissolved in 380 g ethyl acetate / heptane (1: 1 v / v containing 250 ppm BHT) and the solution is washed with 10% aqueous sodium thiosulfate (204 g) followed by 10% aqueous sodium carbonate (214 g). Followed by 200 g of water.

溶液を濃縮して約40mLにして、148gのヘプタン(BHTを含有)を添加した。これを再び蒸留して約40mLにして、全ての酢酸エチルを除去した。ヘプタン(265g)を添加して、得られた混合物を55℃に加熱して、固形物を溶解させた。溶液を約40℃に冷却し、種結晶を添加した。温度が5℃になるまで冷却を続け、その後、スラリーを濾過した。ウエットケーキを冷ヘプタンで洗浄し、その後、生成物を40℃の真空オーブンで乾燥した。   The solution was concentrated to about 40 mL and 148 g heptane (containing BHT) was added. This was distilled again to about 40 mL to remove all ethyl acetate. Heptane (265 g) was added and the resulting mixture was heated to 55 ° C. to dissolve the solid. The solution was cooled to about 40 ° C. and seed crystals were added. Cooling was continued until the temperature reached 5 ° C., after which the slurry was filtered. The wet cake was washed with cold heptane, after which the product was dried in a vacuum oven at 40 ° C.

Claims (7)

4−フルオロベンズアルデヒドとN−ヨードスクシンイミドとを酸媒体中で合わせることにより、4−フルオロ−3−ヨードベンズアルデヒドを製造する方法。   A method for producing 4-fluoro-3-iodobenzaldehyde by combining 4-fluorobenzaldehyde and N-iodosuccinimide in an acid medium. 該酸が有機酸である、請求項1に記載の方法。   The method of claim 1, wherein the acid is an organic acid. 該有機酸がトリフルオロメタンスルホン酸である、請求項2に記載の方法。   The method of claim 2, wherein the organic acid is trifluoromethanesulfonic acid. 該酸が無機酸である、請求項1に記載の方法。   The method of claim 1, wherein the acid is an inorganic acid. 該無機酸が、硝酸、硫酸、及び塩酸からなる群から選択される、請求項4に記載の方法。   The method of claim 4, wherein the inorganic acid is selected from the group consisting of nitric acid, sulfuric acid, and hydrochloric acid. 該酸が、酢酸と組み合わされた無機酸である、請求項1に記載の方法。   The method of claim 1, wherein the acid is an inorganic acid combined with acetic acid. 該無機酸/酢酸の組み合わせが、1:1の比率にある、請求項4に記載の方法。   The method of claim 4, wherein the inorganic acid / acetic acid combination is in a 1: 1 ratio.
JP2003569588A 2002-02-19 2003-02-03 Iodination of 4-fluoro-benzaldehyde Withdrawn JP2005525350A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7861702A 2002-02-19 2002-02-19
PCT/US2003/003082 WO2003070678A1 (en) 2002-02-19 2003-02-03 Iodination of 4-fluoro-benzaldehyde

Publications (1)

Publication Number Publication Date
JP2005525350A true JP2005525350A (en) 2005-08-25

Family

ID=27752716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003569588A Withdrawn JP2005525350A (en) 2002-02-19 2003-02-03 Iodination of 4-fluoro-benzaldehyde

Country Status (5)

Country Link
EP (1) EP1476415A1 (en)
JP (1) JP2005525350A (en)
CA (1) CA2476824A1 (en)
MX (1) MXPA04008072A (en)
WO (1) WO2003070678A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008285473A (en) * 2008-04-07 2008-11-27 Nippo Kagaku Kk Method for producing iodinated aromatic compound
JP5248489B2 (en) * 2007-05-18 2013-07-31 日宝化学株式会社 Method for producing halogenated aromatic compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222000T3 (en) * 1997-12-18 2005-01-16 Abbott Laboratories COMPOUNDS THAT OPEN THE POTASSIUM CHANNELS.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5248489B2 (en) * 2007-05-18 2013-07-31 日宝化学株式会社 Method for producing halogenated aromatic compound
JP2008285473A (en) * 2008-04-07 2008-11-27 Nippo Kagaku Kk Method for producing iodinated aromatic compound

Also Published As

Publication number Publication date
WO2003070678A1 (en) 2003-08-28
MXPA04008072A (en) 2004-11-26
CA2476824A1 (en) 2003-08-28
EP1476415A1 (en) 2004-11-17

Similar Documents

Publication Publication Date Title
Paquette et al. Total synthesis of dodecahedrane
JP4503184B2 (en) Preparation of 2-amino-2- [2- (4-C2-20-alkyl-phenyl) ethyl] propane-1,3-diols
JP6216312B2 (en) Compounds and methods for preparing diarylpropanes
CN110330500B (en) Stereoselective synthesis method of 6 beta-hydroxy-7, 8-dihydro-morphine derivative
JP2000513032A (en) Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
JP2002521352A (en) Method for producing orthoalkylated benzoic acid derivative
JP5019696B2 (en) Reagent for singlet oxygen measurement
JP2005525350A (en) Iodination of 4-fluoro-benzaldehyde
JP4408578B2 (en) 3- (1-Hydroxy-pentylidene) -5-nitro-3H-benzofuran-2-one, production method thereof and use thereof
US20030220526A1 (en) Iodination of 4-fluoro-benzaldehyde
JP4952272B2 (en) (Z)-Method for producing ligustilide
JP5270091B2 (en) Process for preparing 7-alkyl-10-hydroxy-20 (S) -camptothecin
FINDLAY et al. THE SYNTHESIS OF CERTAIN SUBSTITUTED INDOLEACETIC ACIDS1
US20060142595A1 (en) Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI
CN112409434A (en) Synthesis method of dehydroprogesterone
JPH10204021A (en) Production of benzophenone derivative
JPH01186844A (en) Production of 3-(4'-bromobiphenyl)-3-hydroxyl- 4-phenylbutyric ester
JP2701114B2 (en) Method for producing 3'-amino-2'-hydroxyacetophenone
JPS6344733B2 (en)
HU178970B (en) Process for preparing lower alkyl esters of 4,10-dihydro-10-oxo-thieno/3,2-c/ /1/ benzoxepin-8-acetic acid
JPH0332553B2 (en)
JPS60237041A (en) Preparation of 3-propionylsalicylic acid derivative
JP4765167B2 (en) 1- (6-Methylpyridin-3-yl) -2- [4- (methylsulfonyl) phenyl] ethanone and process for producing the same
KR101213467B1 (en) Novel process for the preparation of dihydrate of losartan metabolite exp-3174
SU1321721A1 (en) Method of producing liquid crystalline ethers of trans-6-h-alkyl-decalin-2-carboxylic acid

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060404